127 related articles for article (PubMed ID: 12407758)
1. Reconstruction of geno-phenotypic evolutionary sequences from intracellular patterns of molecular abnormalities in human solid tumors.
Shackney SE; Smith CA; Pollice AA; Silverman JF
Methods Mol Med; 2003; 75():431-49. PubMed ID: 12407758
[No Abstract] [Full Text] [Related]
2. Common patterns of genetic evolution in human solid tumors.
Shackney SE; Shankey TV
Cytometry; 1997 Sep; 29(1):1-27. PubMed ID: 9298807
[TBL] [Abstract][Full Text] [Related]
3. [Immunochemistry and genotype analysis of tumors. Second part: What future for the molecular diagnosis of tumors?].
Soussi T
Ann Pathol; 2002 Apr; 22(2):113-20. PubMed ID: 12124492
[TBL] [Abstract][Full Text] [Related]
4. Molecular cytogenetics: solid tumors and leukemia.
Gray JW; Pallavicini MG
Blood Cells; 1993; 19(3):677-83; discussion 687-9. PubMed ID: 8018948
[TBL] [Abstract][Full Text] [Related]
5. [Genotypic analysis and immunohistochemistry in human cancers: conflicting or complementary information?].
Puisieux A
Ann Pathol; 2002 Apr; 22(2):93-5. PubMed ID: 12124489
[No Abstract] [Full Text] [Related]
6. On the holistic approach in cellular and cancer biology: nonlinearity, complexity, and quasi-determinism of the dynamic cellular network.
Waliszewski P; Molski M; Konarski J
J Surg Oncol; 1998 Jun; 68(2):70-8. PubMed ID: 9624035
[TBL] [Abstract][Full Text] [Related]
7. Rapid Screening of MDR-TB in Cases of Extra Pulmonary Tuberculosis Using Geno Type MTBDRplus.
Kumari R; Tripathi R; Pandey AP; Banerjee T; Sinha P; Anupurba S
PLoS One; 2016; 11(7):e0159651. PubMed ID: 27441660
[TBL] [Abstract][Full Text] [Related]
8. Genotype- or Phenotype-Targeting Anticancer Therapies? Lessons from Tumor Evolutionary Biology.
Escargueil AE; Prado S; Dezaire A; Clairambault J; Larsen AK; Soares DG
Curr Pharm Des; 2016; 22(44):6625-6644. PubMed ID: 27587198
[TBL] [Abstract][Full Text] [Related]
9. Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation.
Ried T; Heselmeyer-Haddad K; Blegen H; Schröck E; Auer G
Genes Chromosomes Cancer; 1999 Jul; 25(3):195-204. PubMed ID: 10379865
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.
Stockley TL; Oza AM; Berman HK; Leighl NB; Knox JJ; Shepherd FA; Chen EX; Krzyzanowska MK; Dhani N; Joshua AM; Tsao MS; Serra S; Clarke B; Roehrl MH; Zhang T; Sukhai MA; Califaretti N; Trinkaus M; Shaw P; van der Kwast T; Wang L; Virtanen C; Kim RH; Razak AR; Hansen AR; Yu C; Pugh TJ; Kamel-Reid S; Siu LL; Bedard PL
Genome Med; 2016 Oct; 8(1):109. PubMed ID: 27782854
[TBL] [Abstract][Full Text] [Related]
11. Cladistic approaches to identifying determinants of variability in multifactorial phenotypes and the evolutionary significance of variation in the human genome.
Templeton AR
Ciba Found Symp; 1996; 197():259-77; discussion 277-83. PubMed ID: 8827378
[TBL] [Abstract][Full Text] [Related]
12. Tumor progression, oncogenes and the evolution of metastatic phenotypic diversity.
Nicolson GL
Clin Exp Metastasis; 1984; 2(2):85-105. PubMed ID: 6543697
[No Abstract] [Full Text] [Related]
13. Genetic and phenotypic heterogeneity of human malignancies: finding order in chaos.
Shackney SE; Shankey TV
Cytometry; 1995 Sep; 21(1):2-5. PubMed ID: 8529466
[TBL] [Abstract][Full Text] [Related]
14. Genotypic and phenotypic classification of cancer: How should the impact of the two diagnostic approaches best be balanced?
Brandal P; Teixeira MR; Heim S
Genes Chromosomes Cancer; 2010 Sep; 49(9):763-74. PubMed ID: 20607708
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemistry and genotype analysis of tumors. First part: Which future for the immunochemical diagnosis of cancer?].
Svrcek M; Sabourin JC
Ann Pathol; 2002 Apr; 22(2):102-12. PubMed ID: 12124491
[TBL] [Abstract][Full Text] [Related]
16. (Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome.
Mussa A; Russo S; De Crescenzo A; Freschi A; Calzari L; Maitz S; Macchiaiolo M; Molinatto C; Baldassarre G; Mariani M; Tarani L; Bedeschi MF; Milani D; Melis D; Bartuli A; Cubellis MV; Selicorni A; Cirillo Silengo M; Larizza L; Riccio A; Ferrero GB
Eur J Hum Genet; 2016 Feb; 24(2):183-90. PubMed ID: 25898929
[TBL] [Abstract][Full Text] [Related]
17. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic and genetic studies in solid tumors: background.
Swansbury J
Methods Mol Biol; 2003; 220():125-33. PubMed ID: 12744211
[TBL] [Abstract][Full Text] [Related]
19. Tumor cell heterogeneity.
Chekhun VF; Sherban SD; Savtsova ZD
Exp Oncol; 2013 Sep; 35(3):154-62. PubMed ID: 24084451
[TBL] [Abstract][Full Text] [Related]
20. [Federal headship of carcinogenesis--genotype, phenotype, and dramatype].
Hino O
Fukuoka Igaku Zasshi; 2005 Jan; 96(1):1-4. PubMed ID: 15839062
[No Abstract] [Full Text] [Related]
[Next] [New Search]
